This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Congenital Malformation of Great Vein, Unspecified대정맥의 선천기형, 상세불명

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: Q26.9 (Congenital malformation of great vein, unspecified) | Special Copayment Reduction: V192 (Special copayment reduction for heart disease: 5% copayment for up to 30 days from the registration date)
B. SynonymsGreat vein malformation NOS, great vein anomaly unspecified, Anomaly of vena cava NOS, Congenital great vein anomaly unspecified
C. Adult onsetWhen a great vein malformation is found in adulthood without detailed classification, precise imaging classification is mandatory before any cardiovascular procedure or surgery. Clinical severity varies from asymptomatic to severe depending on the type of underlying malformation.
1. HistoryEvolution of the ICD Q26 classification system; clinical and administrative use and limitations of code Q26.9
2. CausesEmbryological causes of malformations across the Q26 category; specific malformation not yet classified
3. GeneticsCommon genetic background of congenital heart disease, such as NKX2.5, GATA4, and 22q11.2 deletion
4. General epidemiologyEpidemiology of malformations across Q26; frequency of use of the unspecified code and international status
5. PathophysiologyCommon mechanisms of abnormal great vein development; hemodynamic consequences of abnormal systemic venous return
6. SymptomsWide range from asymptomatic to severe heart failure and cyanosis depending on the underlying malformation
7. SignsSigns of right heart strain or cyanosis; chest radiograph and ECG abnormalities possible
8. ScreeningNeonatal SpO₂ screening, fetal echocardiography; CT/MRI workup if abnormal
9. DiagnosisDefinitive classification by cardiac CT/MRI; cardiac catheterization if needed; recoding to Q26.0–Q26.8
10. TreatmentTreatment per guidelines for the specific malformation after definitive classification; in emergencies, repair after intraoperative anatomical confirmation
11. PrognosisType of underlying malformation and associated cardiac anomalies determine prognosis; early classification and treatment improve prognosis
12. PreventionPrenatal detailed examination, neonatal screening, pre-procedural anatomical confirmation protocol
13. ReferencesCongenital malformations of great veins: anatomy, imaging, and clinical implications … and 9 other papers

1. History

ICD-10 code Q26.9 is a residual code used when a congenital malformation of a great vein is present but cannot be classified under a specific code Q26.0–Q26.8 because clinical information is insufficient or imaging has not been completed. This code reflects an incomplete diagnosis within the clinical and administrative coding system for great vein malformations.

The history of clinical recognition of congenital great vein malformations began with anatomical reports in the 18th–19th centuries. As great vein malformations, including those of the superior vena cava, inferior vena cava, and pulmonary veins, were described individually, the need for systematic classification emerged with advances in cardiovascular medicine in the mid-20th century. When the WHO introduced ICD-10, congenital great vein malformations were systematized under category Q26, and Q26.9 became established as the code for incompletely classified cases.

With the development of medical information systems, minimizing the use of unspecified codes is an international trend. In ICD-11, great vein malformations are subclassified in greater detail, and the frequency of Q26.9 use is expected to decrease. However, Q26.9 is still used for complex great vein malformations, infant deaths, and in healthcare settings in developing countries.

In clinical practice, when encountering a patient coded as Q26.9, it is important to make an effort to quickly identify the underlying malformation. Given the diverse clinical significance of great vein malformations—from asymptomatic variants to life-threatening hemodynamic abnormalities—a persistently unspecified status can pose a risk to patient safety. Therefore, prompt imaging classification and code reclassification for patients registered as Q26.9 is clinically important.

Among congenital heart diseases registered for V192 special copayment reduction in Korea, Q26 category malformations should in principle be confirmed and coded by a cardiologist, and Q26.9 should be used only as a provisional code. Guidelines from the Korean Society of Pediatric Cardiology and the Korean Society for Thoracic and Cardiovascular Surgery also recommend minimizing the use of unspecified codes and prioritizing imaging-based anatomical classification.


2. Causes

The causes of congenital great vein malformations classified as Q26.9 are shared with the malformations of the entire Q26 category. Abnormalities in the remodeling and regression of the cardinal veins, vitelline veins, and umbilical veins involved in great vein formation during embryonic cardiovascular development result in various forms of great vein malformation.

Embryologically, the superior vena cava derives from the anterior cardinal vein, and the inferior vena cava from the combined formation of several venous primordia. Failure or abnormality in this process causes malformations such as Q26.0 (stenosis of vena cava), Q26.1 (absence of vena cava), Q26.8 (other malformations such as PLSVC), and anomalous pulmonary venous connection (Q26.2–Q26.4). Q26.9 applies when the malformation cannot be subclassified as any of these.

Environmental factors (rubella, diabetes, teratogenic drugs) and genetic predisposition are commonly involved, and these malformations often occur as components of complex congenital heart malformations. When the diagnosis is incomplete, causative factors are also difficult to identify, so prompt further testing is important.


3. Genetics

The genetic background of Q26.9 is shared with the entire Q26 category. Variants in cardiac developmental transcription factor genes (NKX2.5, GATA4, TBX5, TBX1) are associated with various congenital heart malformations, and great vein anomalies are included in this spectrum. 22q11.2 microdeletion (DiGeorge syndrome) may be accompanied by great vein anomalies together with multiple cardiac malformations.

Even in patients classified as Q26.9, searching for a genetic cause through karyotyping, chromosomal microarray, or clinical exome sequencing is recommended. Especially when the malformation occurs as a component of a complex congenital heart malformation, identifying the genetic cause provides important information for family recurrence risk counseling and patient management. With advances in whole-genome sequencing technology, the detection rate of genetic causes in congenital malformations of unknown cause is increasing.


4. General epidemiology

The exact epidemiology of congenital great vein malformations ultimately coded as Q26.9 is difficult to determine. Because they are reclassified to Q26.0–Q26.8 once detailed classification is made, the final prevalence of Q26.9 is very low. In medically advanced countries, with the widespread availability of cardiac CT, MRI, and echocardiography, Q26.9 is used only as a temporary code and is rarely retained as the final code.

In international data, some institutions report that patients registered as Q26.9 in congenital heart disease databases account for less than 5% of all Q26 code use. The prevalence of all congenital great vein malformations (Q26 category) is estimated at about 1–2 per 10,000 live births, of which Q26.9 accounts for the smallest proportion. With the standardization of medical records and the adoption of electronic medical records, use of unspecified codes is generally declining.


5. Pathophysiology

The hemodynamic consequences of congenital great vein malformations differ according to the location and type of malformation. Superior vena cava malformations (stenosis, duplication, malposition) cause impaired venous return from the upper limbs and head and neck, and inferior vena cava malformations cause abnormal venous return from the lower limbs and abdominal cavity. When an anomalous pulmonary venous connection remains unclassified, oxygenated blood may enter the right atrium, resulting in a left-to-right shunt or cyanosis.

When using code Q26.9, the clinician must consider all possible hemodynamic consequences of the underlying malformation. Right heart volume overload (left-to-right shunt), cyanosis from a right-to-left shunt, and impaired systemic venous return (superior vena cava syndrome pattern) are all possible clinical situations. While the diagnostic classification is incomplete, identifying the exact type of malformation and its hemodynamic significance through imaging is a prerequisite for deciding the treatment direction.


6. Symptoms

The symptom spectrum of patients coded as Q26.9 is very broad. Malformations such as simple PLSVC draining to the coronary sinus are completely asymptomatic, while malformations such as total anomalous pulmonary venous connection cause severe cyanosis requiring emergency surgery immediately after birth. Therefore, clinical severity cannot be predicted from the Q26.9 code alone.

In Q26.9 patients, clinicians should carefully evaluate for cyanosis, dyspnea, symptoms of right heart failure (edema, ascites, jugular venous distension), and exercise intolerance. The presence and severity of symptoms determine the urgency of imaging. In particular, symptomatic neonates require emergency imaging and specialist consultation.


7. Signs

Physical examination findings vary depending on the type of underlying malformation. Rather than specific signs caused by the great vein malformation itself, the main findings are signs caused by associated cardiac malformations or hemodynamic consequences (murmur, abnormal S2, signs of right heart enlargement, cyanosis). Abnormal mediastinal shadows and abnormal vascular shadows may be seen on chest radiography.

On ECG, right heart hypertrophy, right bundle branch block, right axis deviation, and other findings may appear depending on the type of associated malformation. In cases classified as Q26.9, when such nonspecific findings are present, it is important to confirm the underlying malformation promptly with imaging.


8. Screening

Neonatal pulse oximetry screening (criteria: SpO₂ ≥95% and upper–lower limb difference less than 3%) is effective for early detection of critical congenital heart disease, including anomalous pulmonary venous connection. If great vein–related abnormalities (coronary sinus dilation, abnormal mediastinal vascular shadows, abnormal great vein course) are found on fetal echocardiography, detailed echocardiography and CT/MRI are performed immediately after birth.

In adults, these malformations are often found incidentally on chest CT or echocardiography. Right heart enlargement, abnormal vascular shadows, and an abnormal CVC insertion path serve as clues. Once provisionally coded as Q26.9, a protocol for definitive classification by cardiac CT or MRI as soon as possible is needed.


9. Diagnosis

Cardiac CT angiography (CTA) and cardiac MRI (CMR) are the standard tests for definitive diagnosis and detailed classification of great vein malformations. These tests identify the course and connection sites of the great veins and associated cardiac malformations, and the case must be reclassified to a specific code Q26.0–Q26.8. Echocardiography (transthoracic and transesophageal) is an adjunctive diagnostic tool useful for detecting indirect signs and for hemodynamic assessment.

Cardiac catheterization is performed when measurement of pulmonary vascular resistance, detailed anatomical confirmation, or preoperative evaluation is needed. It is a principle of healthcare quality management that patients classified as Q26.9 must undergo definitive classification through the above tests, and the Q26.9 code must not be retained as the final diagnosis without reclassification to a specific code.


10. Treatment

Treatment of patients coded as Q26.9 is determined according to the guidelines for the specific malformation after definitive classification. When emergency surgery is required (severe cyanosis, accompanying pulmonary venous obstruction), repair is performed after direct intraoperative anatomical confirmation, and Q26.9 is reclassified to a definitive code after surgery. In stable cases, a treatment plan is established after imaging is completed.

When associated cardiac malformations are present, an integrated surgical plan is developed through multidisciplinary consultation between congenital cardiac surgeons and pediatric cardiologists. The anatomy of the great vein malformation must be reflected in the preoperative cardiopulmonary bypass plan; without this information, serious surgical complications can occur.


11. Prognosis

Prognosis is determined by the type of underlying malformation, the presence of associated cardiac malformations, and the timing of surgery. If treatment decisions are delayed while in Q26.9 status, the appropriate treatment window may be missed and the prognosis worsens. When definitive classification and early treatment are achieved, most isolated great vein malformations have a favorable prognosis.

Because long-term retention of the Q26.9 code is itself a healthcare quality management issue, medical institutions should monitor whether definitive classification has been completed for all patients registered as Q26.9. Long-term follow-up monitors complications according to the confirmed malformation (pulmonary vascular disease, arrhythmia, right heart failure).


12. Prevention

'Prevention' for Q26.9 takes place on two levels. First, management of prenatal risk factors (rubella prevention, diabetes control, avoidance of teratogenic drugs, folic acid supplementation) is recommended to prevent congenital great vein malformations themselves. Second, establishing a system for prompt definitive classification to prevent the unspecified status of the Q26.9 code from persisting is a preventive measure at the healthcare system level.

Universal implementation of detailed prenatal echocardiography and neonatal pulse oximetry screening improves early detection of great vein malformations. It is important to prevent procedure-related complications by operating a protocol that confirms the presence of great vein malformations by imaging before any invasive cardiac procedure.


13. References

  1. Demos TC, Posniak HV, Pierce KL, et al. Venous anomalies of the thorax. AJR Am J Roentgenol. 2004;182(5):1139-1150. DOI: 10.2214/ajr.182.5.1821139. PMID: 15100104.

  2. Shuler CO, Black GB, Jerrell JM. Population-based treated prevalence of congenital heart disease in a pediatric cohort. Pediatr Cardiol. 2013;34(3):606-611. DOI: 10.1007/s00246-012-0469-6. PMID: 22871991.

  3. Seale AN, Uemura H, Webber SA, et al. Total anomalous pulmonary venous connection: morphology and outcome from an international population-based study. Circulation. 2010;122(25):2718-2726. DOI: 10.1161/CIRCULATIONAHA.110.940825. PMID: 21135366.

  4. Irwin RB, Greaves M, Schmitt M. Persistent left superior vena cava – considerations in fetal, pediatric and adult populations. Echo Res Pract. 2017;4(2):R33-R40. DOI: 10.1530/ERP-16-0038. PMID: 28191144.

  5. Bartram U, Wirbelauer J, Speer CP. Heterotaxy syndrome – asplenia and polysplenia as indicators of visceral malposition and complex congenital heart disease. Biol Neonate. 2005;88(4):278-290. DOI: 10.1159/000087625. PMID: 16254454.

  6. Sarodia BD, Stoller JK. Persistent left superior vena cava: case report and literature review. Respir Care. 2000;45(4):411-416. PMID: 10772367.

  7. Lacour-Gayet F, Zoghbi J, Serraf AE, et al. Surgical management of progressive pulmonary venous obstruction after repair of total anomalous pulmonary venous connection. J Thorac Cardiovasc Surg. 1999;117(4):679-687. DOI: 10.1016/s0022-5223(99)70289-4. PMID: 10096964.

  8. Karamlou T, Gurofsky R, Al Sukhni E, et al. Factors associated with mortality and reoperation in 377 children with total anomalous pulmonary venous connection. Circulation. 2007;115(12):1591-1598. DOI: 10.1161/CIRCULATIONAHA.106.635581. PMID: 17353443.

  9. Saxena A, Mehta A, Juneja R, et al. Prevalence and pattern of total and partial anomalous pulmonary venous connection in Indian patients with congenital heart disease. Ann Pediatr Cardiol. 2015;8(1):10-15. DOI: 10.4103/0974-2069.149515. PMID: 25684884.

  10. Majdalany DS, Phillips SD, Dearani JA, et al. Isolated partial anomalous pulmonary venous connections in adults: twenty-year experience. Congenit Heart Dis. 2010;5(6):537-545. DOI: 10.1111/j.1747-0803.2010.00427.x. PMID: 21087438.